US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies

Clinical trial NCT04990323 · COMPLETED

Trial details

NCT number: NCT04990323
Sponsor: ExCellThera inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

High Risk Myeloid Malignancies Cord Blood Transplant

Start date: 2021-12-01
Primary completion: 2025-12-31
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.